Articles

CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Department of Statistics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada
Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
Hôpital Maisonneuve-Rosemont, Université de Montréal, QC, Canada
Hamilton Health Sciences Centre and McMaster University, Hamilton, ON, Canada
Leukemia/Bone Marrow Transplant Program of BC, Vancouver General Hospital, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
Princess Margaret Cancer Centre University of Toronto, ON, Canada
Fred Hutchinson Cancer Research Centre, Seattle, WA, USA
Royal Melbourne Hospital and University of Melbourne, Australia
Auckland City and Starship Children’s Hospital, Auckland, New Zealand
Institute of Medical and Veterinary Sciences, Adelaide, Australia
General Hematology, Blood Cancers and Bone Marrow Transplant Program, University of Colorado Hospital, Aurora, CO, USA
King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
BC Children’s Hospital Research Institute and Department of Surgery, University of British Columbia, Vancouver, BC, Canada
Leukemia/Bone Marrow Transplant Program of BC, Vancouver General Hospital, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
Princess Margaret Cancer Centre University of Toronto, ON, Canada
CancerCare Manitoba, Winnipeg, MB, Canada
Hamilton Health Sciences Centre and McMaster University, Hamilton, ON, Canada
Department of Statistics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada
Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
The Hospital for Sick Children and University of Toronto, ON, Canada
Nova Scotia Health Authority and Dalhousie University, Halifax, NS, Canada
Princess Margaret Cancer Centre University of Toronto, ON, Canada
Michael Cuccione Childhood Cancer research Program, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.170928